why choose us

First received: June 08, 2023

Clinical Trial: Cell Cycle Arrest Proteins for Early Diagnosis of Acute Kidney Injury After Lung Transplant

Study Status: Completed

Recruit Status: RECRUITING

Condition: Acute Kidney Injury

Study Type: OBSERVATIONAL


Official Title: Cell Cycle Arrest Proteins for Early Diagnosis of Acute Kidney Injury After Lung Transplant: a Prospective Observational Study

Brief Summary: Renal failure is a common complication of lung transplant (LUTX).Early diagnosis of acute kidney injury (AKI) in this cohort is of utmost importance, since AKI after LUTX is associated with worsened short and long-term outcomes.To now, early biomarkers of renal failure based on the measurement of cell-cycle arrest proteins have never been tested in this population.

Read more